With millions on the line, Alkermes, J&J start arbitration over drug delivery tech dispute Sanofi offloads rights to prolonged-release antipsychotic drug Sol-Gel gets FDA approval for encapsulated skin disease drug Consegna buys Fathom to expand long-acting injectable pipeline FDA swats back Teva, MedinCell's long-acting schizophrenia drug application Featured Story | By Nick Paul Taylor A resolution to Alkermes’ dispute with Johnson & Johnson may have just loomed into view. Months after J&J’s Janssen moved to partially terminate its license pact with Alkermes, the companies have begun arbitration in a bid to reach an agreement. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Sanofi has offloaded the French rights to a prolonged-release and divisible tablet formulations of lithium carbonate to Laboratoires Delbert, a company focused on the revival of essential medicines. read more By Nick Paul Taylor Sol-Gel Technologies’ work to expand the treatment options for patients with the skin condition rosacea has paid off, with the FDA approving a product based on its microencapsulation technology. Galderma will commercialize the topical medicine, Epsolay, in the U.S. read more By Nick Paul Taylor Consegna Pharma is stepping up its bid to use long-acting injectables to combat the opioid crisis, striking a deal to acquire Fathom Pharma and its lead treatment for chronic pain in terminally ill patients. read more By Kevin Dunleavy The FDA has sent a complete response letter to Teva and MedinCell of France, rejecting their bid for approval of a long-acting, subcutaneous version of the decades-old schizophrenia drug risperidone. The companies didn’t disclose the issues identified by the agency. read more Resources Sponsored By: H1 More than 570 clinical trials in Ukraine have been disrupted. Unanticipated disruptions to medical testing and clinical trials impede progress toward new breakthroughs and new therapies that millions of patients around the world hang their hope on. What role do rescue sites play? Sponsored by: United Cargo The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now. Sponsored by: Blue Matter, strategic consultants in the life sciences What’s in store for the oncology market in 2022 and beyond? This paper looks at 5 trends driving the market. Sponsored by: Thermo Fisher Scientific Learn how to position quality as a central component within your raw material sourcing strategies for the chemicals used throughout your workflows. Download the free whitepaper from Thermo Fisher Scientific. Fierce Trial Master File Summit May 2-4, 2022 | New Orleans, LA & Streaming Live Fierce Leaders in Life Sciences Forum May 24, 2022 | Free Virtual Event Fierce Digital Pharma Engage June 14-15, 2022 | Huntington Beach, CA Fierce Digital Pharma Innovation Week June 21-23, 2022 | Free Virtual Event Fierce Health Payer Summit October 12, 2022 | Free Virtual Event Fierce Digital Pharma East October 18-20, 2022 | Philadelphia, PA & October 25-28, 2022 | Virtual Event Fierce Launch Readiness for Medical Affairs & Communications Teams Summit November 30-December 1, 2022 | Free Virtual Event Fierce New Product Planning Summit September 20-22, 2022 | Boston, MA | 